A detailed history of Cibc World Markets Corp transactions in Nkarta, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 11,741 shares of NKTX stock, worth $21,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,741
Holding current value
$21,486
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$1.37 - $2.53 $16,085 - $29,704
11,741 New
11,741 $21,000
Q1 2024

May 13, 2024

BUY
$5.59 - $15.71 $1.12 Million - $3.14 Million
200,000 New
200,000 $2.16 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $89M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.